Mark E. Strome - 31 Dec 2025 SCHEDULE 13D/A Report for Zivo Bioscience Common Stock, par value $.001 per share (ZIVO)

Filing Manager
Mark E. Strome
Reporting Manager
Mark E. Strome
Security
Zivo Bioscience Common Stock, par value $.001 per share
Symbol
ZIVO
Shares outstanding
3,908,612 shares
Disclosed Ownership
472,942 shares
Ownership
12%
Form type
SCHEDULE 13D/A
Filing time
27 Feb 2026, 20:20:36 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Mark E. Strome 12% 472,942 194,303 278,639 /s/ Mark E. Strome Mark E. Strome 0000919484
Strome Group, Inc. 7.1% 278,639 0 278,639 /s/ Mark E. Strome Mark E. Strome/President 0001355526
Strome Investment Management, LP 7.1% 278,639 0 278,639 /s/ Mark E. Strome Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP 0000936711
Strome Mezzanine Fund, LP 0% 0 0 0 /s/ Mark E. Strome Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP, surviving entity of merger 0001713153
Strome Mezzanine Fund II, LP 6.8% 266,198 0 266,198 /s/ Mark E. Strome Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP 0001978360